mitoxantrone hydrochloride

Trials studying mitoxantrone hydrochloride

• phase2A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemiasuspendedn=70
• phase3Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AMLnot yet recruitingn=204
• phase2Mitoxantrone Hydrochloride Liposome and Enlonstobart Combination Treatment in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)not yet recruitingn=43
• phase2Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AMLrecruitingn=72
• phase2Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapiesactive not recruitingn=28
• phase3Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCLactive not recruitingn=193
• phase1GVM±R in Patients With Relapsed or Refractory Aggressive NHLactive not recruitingn=18
• phase2JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancernot yet recruitingn=150